Bristol Myers signs deal with Janux on T cell engager for $50M upfront
Bristol Myers signs deal with Janux on T cell engager for $50M upfront
Contenido no disponible. Consulta la fuente original.
Bristol Myers signs deal with Janux on T cell engager for $50M upfront